Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| PASG | Passage Bio | $7.11 | -$4.56 | -39.09% | 863.8K | $37M | $5.12$20.00 |
| HUBC | Hub Cyber Security | $5.15 | -$2.27 | -30.59% | 576.4K | $16M | $3.09$3,322.50 |
| VACH | Voyager Acquisition Corp. | $9.36 | -$3.52 | -27.33% | 25K | $407M | $8.81$15.68 |
| ZDAI | DirectBooking Technology | $2.98 | -$0.97 | -24.56% | 266.5K | $32M | $2.74$17.60 |
| AGIO | Agios Pharmaceuticals | $26.65 | -$8.49 | -24.16% | 4.5M | $2.1B | $22.24$46.00 |
| EFOI | Energy Focus | $4.93 | -$1.57 | -24.11% | 3.4M | $41M | $1.43$9.84 |
| NNOX | Nano-X Imaging | $2.18 | -$0.67 | -23.51% | 170.6K | $182M | $2.11$5.86 |
| SBC | Sbc Medical Group | $3.54 | -$0.95 | -21.16% | 638.5K | $461M | $2.97$5.75 |
| WSHP | WeShop | $12.59 | -$3.29 | -20.70% | 754.6K | $372M | $4.95$250.00 |
| SIDU | Sidus Space | $4.34 | -$1.02 | -18.97% | 39.2M | $356M | $0.63$5.99 |
| FRMI | Fermi | $5.38 | -$1.18 | -17.94% | 1.8M | $4.1B | $4.47$36.99 |
| STI | Solidion Technology | $6.00 | -$1.18 | -16.39% | 172.6K | $56M | $2.94$33.99 |
| BBGI | Beasley Broadcast Group | $18.10 | -$3.41 | -15.85% | 201.2K | $39M | $3.14$26.37 |
| GLND | Greenland Exploration | $5.17 | -$0.93 | -15.24% | 889.2K | $73M | $5.14$23.00 |
| VWAV | VisionWave | $6.05 | -$1.04 | -14.70% | 797.3K | $139M | $2.06$18.41 |
| MNTS | Momentus | $6.48 | -$1.02 | -13.64% | 2.5M | $43M | $3.11$43.55 |
| LSTA | Lisata Therapeutics | $2.79 | -$0.44 | -13.62% | 93.5K | $29M | $1.81$5.07 |
| TXXS | Listed Funds Trust - 21Shares 2x Long Sui ETF | $4.85 | -$0.72 | -12.88% | 28.2K | - | $3.90$30.70 |
| ASTI | Ascent Solar Technologies | $5.11 | -$0.74 | -12.65% | 1.5M | $55M | $1.10$9.87 |
| ZNTL | Zentalis Pharmaceuticals | $4.07 | -$0.58 | -12.39% | 2M | $329M | $1.13$6.95 |
| FRMM | ETHZilla | $3.77 | -$0.53 | -12.24% | 3.8M | $87M | $1.76$174.60 |
| CRMU | Themes ETF Trust - Leverage Shares 2x Long Crml Daily ETF | $11.03 | -$1.41 | -11.33% | 263.7K | - | $3.99$15.25 |
| GLSI | Greenwich LifeSciences | $24.60 | -$3.14 | -11.32% | 283K | $384M | $7.78$34.10 |
| ACHV | Achieve Life Sciences | $4.54 | -$0.56 | -10.98% | 59K | $272M | $1.96$6.03 |
| PCSA | Processa Pharmaceuticals | $2.79 | -$0.31 | -10.00% | 123.4K | $8.2M | $1.76$19.63 |
| RAYA | Erayak Power Solution Group | $4.22 | -$0.44 | -9.39% | 78.7K | $22M | $3.12$7,370.00 |
| PLSM | Pulsenmore | $3.33 | -$0.32 | -8.76% | 1.8K | $24M | $3.00$10.28 |
| ANAB | AnaptysBio | $49.72 | $4.72 | 10.49% | 772.5K | $1.3B | $11.40$51.43 |
Related Articles
Featured Article
3 Artificial Intelligence (AI) Stocks That Could Go Parabolic
Scott Levine|Aug 13, 2024
These innovative companies are embracing the power of AI in a significant way.
Down 53%. Is Nano-X Imaging a Buy on the Dip?
Cory Renauer|May 30, 2024
Nvidia is holding the stock, but that doesn't necessarily make it a terrific investment for everyday investors.
1 Supercharged Growth Stock Poised to Trounce the S&P 500
George Budwell, PhD|May 23, 2024
This small-cap growth stock has a lot of room to run.
Is Nano-X Imaging Stock a Buy in the New Bull Market?
Alex Carchidi|Mar 26, 2024
With share prices ascending everywhere, this young business has enjoyed a lift.
Nano-X Imaging Could Be Teaming Up With Nvidia, and Its Stock Is Flying. Can It Continue?
Alex Carchidi|Feb 29, 2024
The market is making a lot of assumptions, and some are likely false.
These 2 Healthcare Stocks Are in Nvidia's Portfolio. Should They Be in Yours?
David Jagielski, CPA|Feb 22, 2024
These companies are focused on next-gen technologies that could help transform the healthcare industry.
Got $2,500? Buying Shares of This Medical Device Stock Right Now Could Be a Smart Move
Alex Carchidi|Jul 30, 2023
Nano-X's growth story is starting to pick up speed.
Could Nano-X Imaging Stock Help You Become a Millionaire?
David Jagielski, CPA|Jul 21, 2023
Shares of the healthcare company have already doubled this year.
Where Will Nano-X Imaging Be in 3 Years?
Alex Carchidi|Jul 21, 2023
It'll need to prove that its pay-per-X-ray model is workable in the real world.
2 Red-Hot Growth Stocks That Are Still Over 300% Away From 2021 Highs
David Jagielski, CPA|Jul 12, 2023
Are these stocks likely to continue rising?
